Can being 'In the Zone' help newly diagnosed MS patients?
NCT ID NCT06403631
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at 361 people recently diagnosed with multiple sclerosis to see if experiencing 'flow' (being fully absorbed in an activity) and mindfulness are linked to better mental health. Participants filled out online questionnaires about their mental health, anxiety, depression, and daily activities at the start and again 6 months later. The goal was to understand what psychological resources might help support well-being early in the disease.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward ways to support mental health early after an MS diagnosis using everyday activities and mindfulness.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures relationships, so it cannot prove that flow or mindfulness cause better mental health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
361 people
The number who actually took part.
- Started
-
Nov 2023
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Outpatients of Neurological Units
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * age 18-50 * clinically-definite MS diagnosed (with McDonald's revised criteria) within the previous 12 months * steroid treatment for at least 1 month * written informed consent Exclusion Criteria: * neurological disorders other than MS * psychiatric disorders * severe physical impairment (EDSS=\>8) * pregnancy * current or previous attendance in Mindfulness Based Interventions or Acceptance and Commitment Therapy * severe cognitive impairment in comprehension, attention and execution of inferential-logical operations which could interfere with the ability to fill in questionnaires (equivalent scores 0-1 at Progressive Raven Matrices; score \<11.3 at the visual comprehension of sentences subtest of the Aphasia Neuropsychological Test; score \<37.9 at Symbol Digit Modalities Test; and score \<93.1 at the Brief Test of Intelligence)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azienda Ospedaliera San Camillo Forlanini
Roma, Italy
-
Azienda Ospedaliera Sant'Anna
Como, Italy
-
San Luigi Gonzaga Hospital
Orbassano, Italy
-
University of Bari
Bari, Italy
-
University of Cagliari
Cagliari, Italy
-
University of Catania
Catania, Italy
-
University of Florence
Florence, Italy
-
Università Vita-Salute San Raffaele
Milan, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercise rebuild muscle and balance in MS?
- Can diet ease the crushing fatigue of multiple sclerosis?
- One-Time CAR-T infusion tested against progressive MS
- Can PET scans reveal hidden brain inflammation in MS?
- Can a pill rebuild the Brain's insulation? MS trial puts remyelination to the test
- Migraines and tension headaches may be hidden companions to multiple sclerosis